Multivariate cox regression analysis for predictors of breast cancer specific survival within the whole cohort and ER+ positive cases showed that ADA3/c-MYC co-expression is significantly associated with patients’ outcome independently of tumor grade, stage, size and ER status (Table 5). The gene discussed is TADA3; the disease is breast cancer.